drug · small molecule
lucerastat
Phase 3updated 3mo agoby Idorsia Pharmaceutical Ltd🔗 ChEMBL
Phase 3community read0 votes
Small molecule drug with a maximum clinical stage of Phase 3, with 1 investigational indication.
targets
Ceramide glucosyltransferase
all catalysts(0)
nothing on the calendar yet
Trials studying lucerastat
- phase3A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
- phase1A Study to Assess the Safety, Tolerability and Pharmacokinetics of Lucerastat (CDP923) After Multiple Dosing in Healthy Subjects
- phase1A Study to Assess the Safety and Pharmacokinetics of Lucerastat (OGT 923) in Healthy Subjects
- phase3Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that